Clin Assoc Prof Ng Quan Sing - National Cancer Centre Singapore

Có thể bạn quan tâm

Turn on more accessible mode Turn off more accessible mode Skip Ribbon Commands Skip to main content Turn off Animations Turn on Animations DoctorsProfileNew

Appointment

Find a Condition or Treatment

Find a Doctor

About Us Back to Home Corporate Profile
- Vision & Mission
- NCCS Leadership
- Annual Report
- Awards
- Key Milestones
- Whistle-blowing Policy
Newsroom
- Press Releases
- Check Fake News
Visitors InformationContact Us
- Feedback Form
- Patient Liaison Service
Patient Care Back to Home Specialties & Services
- Goh Cheng Liang Proton Therapy Centre
- Haematology
- Medical Oncology
- Surgery & Surgical Oncology, SGH and NCCS
- Radiation Oncology
- Oncologic Imaging
- Supportive & Palliative Care
- Comprehensive Liver Cancer Clinic
- Cancer Genetics Service
- Lung Multidisciplinary Clinic
- Nursing
- NCCS Oncology @ SKH
- NCCS Oncology Clinic @ CGH
- Department of Psychosocial Oncology
- Cancer Education and Information
Your Clinic Visit
- Book an Appointment
- When seeing a doctor
- Pharmacy
- Medicine
- Charges & Payment
- Financial Aid
- Video Consultation
- Rights & Responsibilities as a Patient
Cancer Information & Patient Support
- For Patients
- For Caregivers
- Publications
- Patient Stories
E-Services
- Make/Change/Cancel Appointment
- Request for Medical Report
- Health Buddy App
Find a Doctor
Research & Innovation Back to Home Research Labs
- Cellular & Molecular Research
- Medical Sciences
- Clinical Trials & Epidemiological Sciences
- NCCS Research Committee & Scientific Advisory Board
- Research Divisions Organisation Chart
Programmes
- Disease Focus
- Research Themes
- Joint Breast Cancer Registry
- Asia-Pacific Hepatocellular Carcinoma Trials Group
- The VICTORY Consortium
- ANCHOR
Facilities
- Overview
- Specialised Units
- Shared Facilities
- Shared Services
- Research Contracts and Commercialisation
Our Researchers
- Division of Medical Oncology
- Division of Surgery & Surgical Oncology, SGH and NCCS
- Division of Radiation Oncology
- Division of Oncologic Imaging
- Division of Supportive and Palliative Care
- Cellular and Molecular Research
- Division of Medical Sciences
- Clinical Trials & Epidemiological Sciences
- Research Biennial Book
Clinical Trials
- About Clinical Trials
- Current Clinical Trials
- ECRU
- About Clinical Trials & Epidemiological Sciences
- Clinical Trials Office
- Biostatistics and Epidemiology Unit
SingHealth Research
Education & Training Back to Home OverviewDivision of Cancer Education
- Undergraduate Education Unit
- Postgraduate Education Unit
- Nursing Education Unit
- Faculty Development & Support Education Unit
- Primary Care Oncology Education Unit
- Communications, Mentoring, Ethics and Professionalism Education Unit
- Medical Humanities Education Unit
EventsSingHealth Academy
Careers Back to Home Sponsorship
- Career Conversion Programme
Scholarships
Giving Back to Home Why Give
- About Us
- Funding Innovative Research
- Preventing Cancer
- Advancing Medical Education
- Helping Our Patients
- Furthering Donor Impact
- How Your Gift Helps
Get Involved
- Honouring Your Gift
- Become a Corporate Donor
- Leave Your Legacy
- Fundraise for Us
- Join a Special Event
Your Gift at Work
- Stories of Hope
- Researchers in Action
- Support for Patients
- Our Work in the Community
- Training Future Experts
Be Informed
- Our Publications
- Financial Statements
Make a GiftOur Campaign
- Make More Survivors
- Jeans For Genes
- Women VS Cancer
- BCAM 2024
- LCAM 2023
Volunteer

Home to skip to the main content on a page to skip to the main content on a page

Facebook
WhatsApp
Email Us
share
Font Resize
- A-
- A
- A+
Print

Oncologist - Cancer Doctor: Ng Quan Sing | National Cancer Centre Singapore Back To Search Results

Clin Assoc Prof Ng Quan Sing

Clinical Appointments

Senior Consultant Division of Medical Oncology National Cancer Centre Singapore

Academic Appointments

Clinical Senior Lecturer

Profile

Dr Ng is a Senior Consultant Medical Oncologist at the National Cancer Centre Singapore, sub-specializing in genitourinary, thoracic, head and neck, and nasopharyngeal cancers. He completed his medical training at Imperial College, University of London, and is a member of the Royal College of Physicians in the United Kingdom. He is a clinician scientist, and is a current recipient of the National Medical Research Council research grant to develop new drugs for the treatment of cancer. He was awarded the Doctor of Medicine degree by University College London for his research into novel vascular targeting anti-cancer drugs. He is also actively involved in research to develop functional imaging as a biomarker in oncology. He was awarded the Cancer Research UK research fellowship as well as the British Oncological Association Young Investigator Award for his work. His research has been widely published in both oncology and radiology journals. He is actively involved in medical education. He is clinical senior lecturer at the Yong Loo Lin School of Medicine, National University of Singapore, as well as research mentor to Duke-NUS Medical School students.

Education

MBBS
MRCP (UK)
Doctor of Medicine

View More +

Professional Appointments and Committee Memberships

Senior Consultant, Department of Medical Oncology, National Cancer Centre Singapore
European Society of Medical Oncology, Member, 2009 - present
Royal College of Physicians (United Kingdom), Member, 2003 - present

View More +

Awards

International Cancer Imaging Society Poster Presentation Prize 2014
European Congress of Radiology Best Scientific Paper (Chest) 2007
British Oncological Association Young Investigator Award 2005
Cancer Research UK Fellowship 2005
FECS/AACR/ASCO Fellowship – Methods in Clinical Cancer Research Workshop 2005
SingHealth Service Quality Award (Silver) 2011

View More +

Research Interests

Clinical trials of novel therapeutics in all tumour types, with special interests in lung cancers, urological cancers, head and neck cancers, and nasopharyngeal cancer
Early phase clinical trials incorporating multimodality, multi-parametric functional imaging as predictive and prognostic biomarkers

View More +

Publications

Rajasekaran T, Ng QS, Tan DS, Lim WT, Ang MK, Toh CK, Chowbay B, Kanesvaran R, Tan EH. Metronomic chemotherapy: A relook at its basis and rationale. Cancer Lett. 2017 Mar 1;388:328-333. doi: 10.1016/j.canlet.2016.12.013. Epub 2016 Dec 18.
Sutiman N, Tan SW, Tan EH, Lim WT, Kanesvaran R, Ng QS, Jain A, Ang MK, Tan WL, Toh CK, Chowbay B. J Thorac Oncol. EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients. 2016 Nov 28. pii: S1556-0864(16)33533-X. doi: 10.1016/j.jtho.2016.11.2225.
Rajasekaran T, Ng QS, Tan DS, Lim WT, Ang MK, Toh CK, Chowbay B, Kanesvaran R, Tan EH. Metronomic chemotherapy: A relook at its basis and rationale. Cancer Lett. 2016 Dec 18;388:328-333. doi: 10.1016/j.canlet.2016.12.013.
Tai WM, Yong WP, Lim C, Low LS, Tham CK, Koh TS, Ng QS, Wang WW, Wang LZ, Hartano S, Thng CH, Huynh H, Lim KT, Toh HC, Goh BC, Choo SP. A phase Ib study of selumetinib (AZD6244, ARRY-142886) in com Metformin Use in Relation With Survival Outcomes of Patients With Renal Cell Carcinoma bination with sorafenib in advanced hepatocellular carcinoma (HCC). Ann Oncol. 2016 Sep 28. pii: mdw415
Sutiman N, Zhang Z, Tan EH, Ang MK, Tan SD, Toh CK, Ng QS, Chowbay B, Lim WT. Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules. PLoS One. 2016 May 2;11(5):e0154316. doi: 10.1371/journal.pone.0154316
Tan WL, Tan EH, Lim DW, Ng QS, Tan DS, Jain A, Ang MK. Advances in systemic treatment for nasopharyngeal carcinoma. Chin Clin Oncol. 2016 Apr;5(2):21. doi: 10.21037/cco.2016.03.03.
Ching BC, Tan HS, Tan PH, Toh CK, Kanesvaran R, Ng QS, Tan MH. Differential radiologic characteristics of renal tumours on multiphasic computed tomography. Singapore Med J. 2016 Apr 19. doi: 10.11622/smedj.2016081.
Cheng JJ, Li H, Tan HS, Tan PH, Ng LG, Ng QS, Toh CK, Kanesvaran R, Tan MH. Metformin Use in Relation With Survival Outcomes of Patients With Renal Cell Carcinoma. Clin Genitourin Cancer. 2016 Apr;14(2):168-75. doi:10.1016/j.clgc.2015.12.012

View More +

Research Trials

A Two-Arm, Open-label, Randomized Phase II Study of Pembrolizumab (MK-3475) Monotherapy versus Standard Chemotherapy in Platinum Pre-treated, Recurrent or Metastatic Nasopharyngeal Cancer (NPC), 2016

View More +

Tags: Medical Oncology, Head ＆ Neck, Uro-Oncology, Thoracic-Oncology, Bladder Cancer, Head and Neck Cancer, Kidney Cancer, Laryngeal Cancer, Larynx Cancer, Lung Cancer, Nasopharyngeal Cancer (Nose Cancer), Prostate Cancer, Testicular Cancer, Thoracic Cancers